Atea Pharmaceuticals (AVIR) EBT Margin (2021)
Historic EBT Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2021 value amounting to 63.08%.
- Atea Pharmaceuticals' EBT Margin changed N/A to 63.08% in Q4 2021 from the same period last year, while for Sep 2022 it was 18.75%, marking a year-over-year decrease of 51300.0%. This contributed to the annual value of 39.44% for FY2021, which is 619500.0% up from last year.
- As of Q4 2021, Atea Pharmaceuticals' EBT Margin stood at 63.08%.
- In the past 5 years, Atea Pharmaceuticals' EBT Margin ranged from a high of 63.08% in Q4 2021 and a low of 67.34% during Q3 2021